Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
62.9M
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
69.4K
-
Shares change
-
+17.4K
-
Total reported value, excl. options
-
$667K
-
Value change
-
+$168K
-
Number of buys
-
2
-
Number of sells
-
-1
-
Price
-
$9.62
Significant Holders of MACROGENICS INC - COM (MGNX) as of Q4 2023
3 filings reported holding MGNX - MACROGENICS INC - COM as of Q4 2023.
MACROGENICS INC - COM (MGNX) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 69.4K shares
of 62.9M outstanding shares and own 0.11% of the company stock.
Largest 10 shareholders include Bellevue Group AG (9.95M shares), BlackRock Inc. (6.14M shares), T. Rowe Price Investment Management, Inc. (5.64M shares), ARMISTICE CAPITAL, LLC (4.57M shares), VANGUARD GROUP INC (4.31M shares), RA CAPITAL MANAGEMENT, L.P. (4.05M shares), Frazier Life Sciences Management, L.P. (2.4M shares), STATE STREET CORP (2.17M shares), GEODE CAPITAL MANAGEMENT, LLC (1.4M shares), and WASATCH ADVISORS LP (1.3M shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.